Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results: https://www.marketbeat.com/logos/articles/med_20240829092536_affirm-shows-buy-now-pay-later-is-here-to-stay-in.jpg
Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results

Affirm (NASDAQ: AFRM) has seen wild fluctuations in its stock price over the past three years. Shares peaked at nearly $169 in November 2021 but are down 80% from that level today. However

Expanding Its "Partner Ecosystem" Could Reignite Growth at OKTA: https://www.marketbeat.com/logos/articles/med_20240829085736_expanding-its-partner-ecosystem-could-reignite-gro.jpg
Expanding Its "Partner Ecosystem" Could Reignite Growth at OKTA

Okta’s (NASDAQ: OKTA) stock price has had a difficult few years. Since August of 2021, shares are down around 63%. However, over the past 52 weeks, the stock is recovering, up 34%. The

Buy the Dip In NVIDIA, But Be Prepared for Volatility: https://www.marketbeat.com/logos/articles/med_20240829075756_chart-nvda-8292024.png
Buy the Dip In NVIDIA, But Be Prepared for Volatility

Given the trends and consensus forecast, NVIDIA (NASDAQ: NVDA) had a smoking hot quarter, and new stock price highs will likely come soon, probably before the end of the year.  The catch is that

Netflix Stock Is Back At Highs With A Lot More To Come: https://www.marketbeat.com/logos/articles/med_20240829073542_netflix-stock-is-back-at-highs-with-a-lot-more-to.jpg
Netflix Stock Is Back At Highs With A Lot More To Come

And just like that, the streaming giant and tech titan Netflix Inc (NASDAQ: NFLX) is back at all-time highs. It will be a welcome occasion for investors and long-term fans who've been following

3 Best Growth Stocks to Own for the Next 10 Years: https://www.marketbeat.com/logos/articles/med_20240827123612_3-best-growth-stocks-to-own-for-the-next-10-years.jpg
3 Best Growth Stocks to Own for the Next 10 Years

During times of market volatility, it’s always good for long-term investors to take a breath and zoom out. That doesn’t mean getting out of the markets as fast as possible. Instead, it means

Workday Stock Perks Up on Results; New Highs Possible This Year: https://www.marketbeat.com/logos/articles/med_20240826111934_chart-wday-8262024.png
Workday Stock Perks Up on Results; New Highs Possible This Year

Workday (NASDAQ: WDAY) stock price is up 30% from the recent low and will head higher because of its results, operational quality, and analysts' sentiment. The combination has the market on

Don’t Let Peloton Take You For a Ride: What You Need to Know: https://www.marketbeat.com/logos/articles/med_20240826075608_chart-pton-8262024.png
Don’t Let Peloton Take You For a Ride: What You Need to Know

Peloton (NASDAQ: PTON) wowed the market with its FQ4 results, sending its shares up nearly 50% in two days. This indicates a dynamic shift that could increase its price over the coming quarters

Intuit Stock Drops Sharply on Profit Concerns: Is It a Buy?: https://www.marketbeat.com/logos/articles/med_20240826080306_intuit-stock-drops-sharply-on-profit-concerns-is-i.jpg
Intuit Stock Drops Sharply on Profit Concerns: Is It a Buy?

On a day when stocks rallied on expectations of lower interest rates, Intuit Inc. (NASDAQ: INTU) was the biggest loser on the S&P 500. Shares of the financial services company known for the

3 Stocks Mega Investors Are Buying Right Now: https://www.marketbeat.com/logos/articles/med_20240826075515_3-stocks-mega-investors-are-buying-right-now.jpg
3 Stocks Mega Investors Are Buying Right Now

During the past two weeks, investors have scrutinized the stock market closely, especially as the S&P 500 just recovered from one of its worst selloffs in 2024. There is doubt as to whether any

Meta And The Case For A 20% Rally Before Christmas: https://www.marketbeat.com/logos/articles/med_20240826072712_meta-and-the-case-for-a-20-rally-before-christmas.jpg
Meta And The Case For A 20% Rally Before Christmas

Despite falling close to 20% during the late July / early August selloff, shares of tech titan Meta Inc (NASDAQ: META) have already recovered. They’ve done more than just recover, in fact, as they

NVIDIA: Analysts Bullish Ahead of Earnings - is it a Buy Now?: https://www.marketbeat.com/logos/articles/med_20240826071029_nvidia-analysts-bullish-ahead-of-earnings---is-it.jpg
NVIDIA: Analysts Bullish Ahead of Earnings - is it a Buy Now?

As NVIDIA (NASDAQ: NVDA) prepares to report its fiscal second-quarter earnings on Wednesday, August 28, after the market close, a surge of analyst upgrades has captured investor attention. With

3 Surging Call Options and What They Mean for Investors: https://www.marketbeat.com/logos/articles/med_20240823155735_3-surging-call-options-and-what-they-mean-for-inve.jpg
3 Surging Call Options and What They Mean for Investors

Investing in stock options can also bring extended rewards at the expense of higher risks. The main risks come through timing, as investors need to have the direction and timing correct for an

Rate Cuts a Near Certainty: 3 Stocks You Might Have Missed: https://www.marketbeat.com/logos/articles/med_20240822145512_rate-cuts-a-near-certainty-3-stocks-you-might-have.jpg
Rate Cuts a Near Certainty: 3 Stocks You Might Have Missed

With cooling inflation and moderating economic growth, the current economic environment strongly suggests that the Federal Reserve is on the verge of cutting interest rates. Market analysts are

Lumen: Among Top Performers Last Month, Still Has Warning Signs: https://www.marketbeat.com/logos/articles/med_20240823085312_lumen-among-top-performers-last-month-still-has-wa.jpg
Lumen: Among Top Performers Last Month, Still Has Warning Signs

Lumen Technologies (NYSE: LUMN) has experienced skyrocketing share price in the last month, making it one of the top-performing stocks based on total 30-day returns in the area of 323% as of

Baidu's Strong Quarter Proves a Smart Pick for Michael Burry: https://www.marketbeat.com/logos/articles/med_20240823082705_baidus-strong-quarter-proves-a-smart-pick-for-mich.jpg
Baidu's Strong Quarter Proves a Smart Pick for Michael Burry

Recently, investors have had the chance to gain insight into the portfolios of Wall Street’s mega investors, from Warren Buffett and his multi-billion dollar positions and portfolio shifts to

Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy: https://www.marketbeat.com/logos/articles/med_20240823081440_inuit-beats-q4-earnings-ai-dividends-and-a-growth.jpg
Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy

Intuit Inc. (NASDAQ: INTU) is the financial technology powerhouse behind TurboTax, Credit Karma, QuickBooks, and Mailchimp. The company continues to demonstrate its dominance in the market with

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R): https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an

Moderna erhält von der Europäischen Kommission die Genehmigung für den RSV-Impfstoff mRESVIA(R): https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Moderna erhält von der Europäischen Kommission die Genehmigung für den RSV-Impfstoff mRESVIA(R)

CAMBRIDGE, MASSACHUSSETTS / ACCESSWIRE / 23. August 2024 / Moderna, Inc. (NASDAQ: MRNA) hat heute bekannt gegeben, dass die Europäische Kommission (EC) die Marktzulassung für mRESVIA

4 No-Brainer Stocks to Hold This Fall for Steady Gains: https://www.marketbeat.com/logos/articles/med_20240822095445_4-no-brainer-stocks-to-hold-this-fall-for-steady-g.jpg
4 No-Brainer Stocks to Hold This Fall for Steady Gains

When markets get volatile, investors of any size and background tend toward certainty in business models and predictability in cash flows. Fitting this category are stocks in the consumer staples

Is Tesla’s Rebound Just Starting? Why You Should Consider Buying: https://www.marketbeat.com/logos/articles/med_20240821093803_is-teslas-rebound-just-starting-why-you-should-con.jpg
Is Tesla’s Rebound Just Starting? Why You Should Consider Buying

The late July and early August sell-off may have spooked many investors, but it also opened up some very tempting entry opportunities. Already, we’re seeing market-wide recovery rallies reclaim

Stanley Druckenmiller's Latest Bet: MELI—Should You Follow Suit?: https://www.marketbeat.com/logos/articles/med_20240821080517_stanley-druckenmillers-latest-bet-melishould-you-f.jpg
Stanley Druckenmiller's Latest Bet: MELI—Should You Follow Suit?

Stanley Druckenmiller, a renowned investor with a stellar track record, has made headlines with his family office, Duquesne, selling its position in NVIDIA (NASDAQ: NVDA) after accurately

Are Tech Stocks Making a Comeback? 3 Top Picks Leading the Way: https://www.marketbeat.com/logos/articles/med_20240820141254_are-tech-stocks-making-a-comeback-3-top-picks-lead.jpg
Are Tech Stocks Making a Comeback? 3 Top Picks Leading the Way

After the brief sell-off in the S&P 500 sparked by the so-called “carry trade” between the U.S. dollar and the Japanese yen, most investors thought that the bullish wave taking over the technology

3 High P/E Stocks That Are Still Worth Buying Right Now: https://www.marketbeat.com/logos/articles/med_20240819134053_3-high-pe-stocks-that-are-still-worth-buying-right.jpg
3 High P/E Stocks That Are Still Worth Buying Right Now

One of the most common fundamental metrics that investors use to analyze stocks is the price-to-earnings (P/E) ratio. This ratio tells you how much you’re paying for $1 of a company’s profits. The

Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?: https://www.marketbeat.com/logos/articles/med_20240818191248_chartb-mrna.jpg
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?

Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. The company disappointed investors when it revised